What is the differential diagnosis for a 50-year-old male with retroviral infection, severe anemia, impaired renal function, and leg swelling?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 16, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Differential Diagnosis for HIV-Infected Patient with Severe Anemia, Renal Impairment, and Leg Swelling

The most critical differential diagnoses to consider in this 50-year-old HIV-positive male with severe anemia (Hb 6.5 g%), leukopenia, acute kidney injury (creatinine 2.9), and unilateral leg swelling are: HIV-associated thrombotic microangiopathy (TMA), HIV-associated nephropathy (HIVAN), parvovirus B19-induced pure red cell aplasia, and HIV immune complex glomerulonephritis. 1, 2

Primary Hematologic Differentials

HIV-Associated Thrombotic Microangiopathy

  • TMA should be the first consideration given the triad of severe anemia, renal dysfunction, and potential microangiopathic process 1, 3, 2
  • Obtain peripheral blood smear immediately to identify schistocytes (>1% supports TMA diagnosis) 3, 4, 5
  • Check platelet count urgently—thrombocytopenia combined with hemolytic anemia and renal failure strongly suggests TMA 3, 4, 2
  • Measure LDH, haptoglobin, indirect bilirubin, and reticulocyte count to confirm hemolysis 3, 5
  • Order ADAMTS13 activity level stat to exclude thrombotic thrombocytopenic purpura (TTP), which requires immediate plasma exchange 3, 5
  • HIV-associated TMA occurs independently of CD4 count and can present even with undetectable viral loads 2

Parvovirus B19-Induced Pure Red Cell Aplasia

  • This diagnosis is critical because it is highly treatable with intravenous immunoglobulin and predominantly occurs in advanced immunodeficiency 6, 7
  • The combination of severe normocytic anemia with absent or extremely low reticulocytes in an afebrile HIV patient without renal dysfunction suggests B19-PRCA 6, 7
  • Order parvovirus B19 DNA PCR on serum or bone marrow—serological methods (IgM/IgG) are unreliable in HIV patients due to lack of antibody production 6, 7
  • Bone marrow biopsy showing PRCA with giant pronormoblasts confirms diagnosis 6, 8
  • Most patients with CD4+ counts ≤100 cells/mm³ relapse within 6 months after initial IVIg therapy and require maintenance treatment 6

Drug-Induced Bone Marrow Suppression

  • Zidovudine causes dose-dependent bone marrow suppression leading to anemia and leukopenia 9, 6
  • Ganciclovir (used for CMV prophylaxis/treatment) causes significant myelosuppression 1
  • Trimethoprim-sulfamethoxazole (Pneumocystis prophylaxis) can cause cytopenias 1
  • Review all current antiretroviral and prophylactic medications 1

Renal-Based Differentials

HIV-Associated Nephropathy (HIVAN)

  • HIVAN with collapsing focal segmental glomerulosclerosis remains prevalent despite antiretroviral therapy and can present with acute kidney injury 1
  • Obtain urinalysis looking for proteinuria (typically nephrotic-range in HIVAN) and microscopic hematuria 1
  • Check spot urine protein-to-creatinine ratio 1
  • Kidney biopsy is essential when feasible to distinguish HIVAN from other HIV-related kidney diseases, as pathological diagnosis guides therapy 1
  • APOL1 high-risk variants (G1, G2) are strong predictors of HIVAN in patients of African ancestry 1

HIV Immune Complex Glomerulonephritis

  • The spectrum includes IgA nephropathy, membranoproliferative glomerulonephritis, membranous nephropathy, and lupus-like GN 1, 2
  • These conditions can occur even with undetectable viral loads and adequate antiretroviral therapy 1
  • Check complement levels (C3, C4, CH50) to evaluate for complement-mediated disease 1, 4
  • Obtain cryoglobulins, as cryoglobulinemic glomerulonephritis can occur with HIV 1
  • Hepatitis C coinfection increases risk of immune complex disease—check HCV antibody and RNA if positive 1

Acute Tubular Necrosis from Sepsis

  • Given the six-week fever history and previous cellulitis treatment, ongoing infection with sepsis-induced ATN is possible 1
  • Check procalcitonin and C-reactive protein to assess for bacterial infection 1
  • Blood cultures should be obtained if fever persists 1
  • Consider occult infections: tuberculosis, disseminated fungal infections, or bacterial endocarditis 1

Additional Critical Differentials

Hemophagocytic Lymphohistiocytosis (HPS)

  • HPS presents with fever, cytopenias, hepatosplenomegaly, and can occur with viral infections (CMV, EBV, HHV-6/8) or opportunistic infections in HIV patients 1
  • Check ferritin (markedly elevated), triglycerides, fibrinogen (low), and soluble IL-2 receptor 1
  • Bone marrow biopsy shows hemophagocytosis 1
  • This carries poor prognosis and requires urgent recognition 1

Opportunistic Infections Causing Cytopenias

  • CMV infection commonly causes anemia and can involve multiple organ systems including kidneys 1
  • Check CMV PCR (viral load) in blood 1
  • Disseminated Mycobacterium avium complex (MAC) causes fever, anemia, and cytopenias 1
  • Consider mycobacterial blood cultures 1

Medication-Induced Thrombotic Microangiopathy

  • Calcineurin inhibitors (if patient received transplant or other indication) can cause TMA 1, 5
  • Review complete medication history for quinine, certain antibiotics, and chemotherapy agents 5

Diagnostic Algorithm

Immediate Priority Tests (Stat):

  1. Peripheral blood smear for schistocytes and red cell morphology 3, 5
  2. ADAMTS13 activity level 3, 5
  3. Complete blood count with differential and platelet count 3, 5
  4. Reticulocyte count 3, 5
  5. LDH, haptoglobin, indirect bilirubin 3, 5
  6. Direct antiglobulin test (Coombs) to exclude immune hemolysis 3

Urgent Tests (Within 24 Hours):

  1. Parvovirus B19 DNA PCR 6, 7
  2. Urinalysis with microscopy and urine protein-to-creatinine ratio 1
  3. Complement levels (C3, C4, CH50) 1, 4
  4. Cryoglobulins 1
  5. CMV PCR (viral load) 1
  6. Blood cultures if febrile 1
  7. Hepatitis B and C serologies 1

Consider Based on Initial Results:

  1. Kidney biopsy if proteinuria present or TMA suspected 1, 2
  2. Bone marrow biopsy if reticulocyte count extremely low or pancytopenia unexplained 6, 8, 7
  3. Ferritin, triglycerides, fibrinogen, soluble IL-2 receptor if HPS suspected 1
  4. Mycobacterial blood cultures if prolonged fever 1

Critical Pitfalls to Avoid

  • Do not delay plasma exchange if ADAMTS13 activity returns <10%—this is life-saving for TTP 3, 5
  • Do not rely on parvovirus B19 serology (IgM/IgG)—use DNA PCR only, as HIV patients often lack antibody response 6, 7
  • Do not transfuse platelets in suspected TMA unless life-threatening bleeding occurs, as this may worsen thrombosis 3, 5
  • Do not attribute all findings to "HIV-related anemia of chronic disease" without excluding treatable causes 6, 7
  • Do not assume undetectable viral load excludes HIV-specific kidney disease—HIVAN and immune complex GN occur despite adequate antiretroviral therapy 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Treatment of Microangiopathic Hemolytic Anemia (MAHA)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Diagnosis and Treatment of Hemolytic Uremic Syndrome (HUS)

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Distinguishing and Managing TTP, HUS, and MAHA

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Parvovirus B19-related anemia in HIV-infected patients.

AIDS patient care and STDs, 2000

Research

Refractory anaemia in an immunocompromised patient--what is it?

The Journal of the Association of Physicians of India, 2013

Research

The efficacy of erythropoietin in human immunodeficiency virus-infected end-stage renal disease patients treated by maintenance hemodialysis.

American journal of kidney diseases : the official journal of the National Kidney Foundation, 1995

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.